Financials
Financial year 2025
Crohn - en Colitis ulcerosa Vereniging vzw from Leuven, company number BE0422701650, closed financial year 2025 with a result of € 83,637 after tax. For that financial year Crohn - en Colitis ulcerosa Vereniging vzw recorded revenue of € 220,087 and equity of € 145,436. Compared with financial year 2024, the result moved from € 8,497 to € 83,637. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 2, 2026.
€ 145,436
▲ 135% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 83,637
▲ € 75,140 vs 2024
Profit after tax over the fiscal year.
€ 158,566
▲ 19% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
€ 35,429
▲ 7% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 122
▼ 96% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 8,534
▼ 48% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 63,427 | - | € 86,941 | € 220,087 | ▲ 153% |
| Gross margin | € 6,533 | € -2,153 | € 42,100 | € 119,493 | ▲ 184% |
| Profit after taxes | € -33,263 | € -38,499 | € 8,497 | € 83,637 | ▲ € 75,140 |
| Equity | € 91,801 | € 53,302 | € 61,799 | € 145,436 | ▲ 135% |
| Total debts | € 29,398 | € 19,017 | € 81,663 | € 27,354 | ▼ 67% |
| Cash | € 99,183 | € 64,217 | € 133,364 | € 158,566 | ▲ 19% |
| Retained profit | € 91,801 | € 53,302 | € 61,799 | € 145,436 | ▲ 135% |
| Balance sheet total | € 121,199 | € 72,319 | € 143,462 | € 172,790 | ▲ 20% |
Key figures of Crohn - en Colitis ulcerosa Vereniging vzw, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Crohn - en Colitis ulcerosa Vereniging vzw?
What happened at Crohn - en Colitis ulcerosa Vereniging vzw in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Mark De Backer stepped down as director. NBB
- Frieda Wieme stepped down as director. NBB
- Gemma Reynders-Broos stepped down as director. NBB
- Mariëlle De Ridder stepped down as director. NBB
- Kristien Amter stepped down as director. NBB
- Colette Baisier stepped down as director. NBB
- Kathleen Van Swalm stepped down as director. NBB
- Ilse De Clercq stepped down as director. NBB
In short
From € 33,263 loss in 2022 to € 83,637 profit in 2025.
Best year ever: 2025, with € 83,637 profit.
A new publication or filing at Crohn - en Colitis ulcerosa Vereniging vzw? We notify you, reason included.
Follow Crohn - en Colitis ulcerosa Vereniging vzwDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Mark De Backer
Director
· until 2027
Frieda Wieme
Director
· until 2027
Gemma Reynders-Broos
Director
· until 2027
Mariëlle De Ridder
Director
· until 2027
Kristien Amter
Director
· until 2027
Colette Baisier
Vice-chairman of the board
· until 2027
Kathleen Van Swalm
Director
· until 2027
Ilse De Clercq
Director
· until 2027
Lynn Debrun
Chairman of the board
· until 2027
Establishments
Establishment units
Physical locations of this company
Groeneweg 151
3001 Leuven
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0422.701.650
- VAT number
- BE 0422.701.650
- Registered office
- Groeneweg 151, 3001 Leuven
- Names & denominations
- Crohn - en Colitis ulcerosa Vereniging vzw · CCC-vzw · Vereniging voor patiënten met een inflammatoire darmziekte (I.B.D.)
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 20 December 1981
- Peppol
- Active · Active since 24 Nov 2023
- Activities · NACE
Verenigingen op het vlak van ziektepreventie en gezondheidsbevordering